February 5, 2014
Dainippon Sumitomo Pharma (DSP) announced on January 31 that it has entered into an agreement with the US-based (California) bioventure Edison Pharmaceuticals, which is engaged in drug discoveries for mitochondrial disease, to expand their collaborations by partially amending the existing...read more